Lindbrook Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Lindbrook Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-191	Closed	-$4.6K	–	2910
2023 Q1	$4.6K	Hold	191	–	–	﹤0.01%	1885
2022 Q4	$2.02K	Buy	191 +133	+229%	+$1.07K	﹤0.01%	2225
2022 Q3	$0	Buy	+58	New	+$264	﹤0.01%	2999

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Lindbrook Capital's PRVB Position: Q2 2023 in Review

Lindbrook Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 191 shares — an estimated $4.6K sold.

Lindbrook Capital first reported a position in PRVB in Q3 2022 and held it in 3 quarters. The position peaked at $4.6K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Lindbrook Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Lindbrook Capital sold 191 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $4.6K.
Lindbrook Capital first reported a position in Provention Bio, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Lindbrook Capital's Provention Bio, Inc. Common Stock position peaked at $4.6K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.